IRVINE, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V:ID) (OTCQB:IDTLF) (Frankfurt:8ID), a trusted leading provider of HIPAA compliant  email security, announced today CyberKnife Center of Miami, a world-class stereotactic radiosurgery practice, has elected to leverage Delivery Trust™ email security to safeguard their client’s sensitive information and maximize HIPAA compliance.

CyberKnife Center of Miami has made its mark on the medical community by providing a much-needed treatment alternative for those suffering from numerous types of cancerous and non-cancerous tumors and lesions. Executive Director Dr. James G. Schwade stated, “We handle an immense amount of sensitive data regarding our clients’ conditions. When communicating between patients and referring physicians, having a secure, yet simple accessibility to client information is essential and Delivery Trust has been a superior product for our application.”

With over 30 million medical records breached so far in 2017 alone (, the healthcare industry is consistently one of the most targeted sectors for cybercriminals.

Identillect CEO, Todd Sexton states, “We are seeing a consistently increasing awareness in the healthcare industry for usable security when communicating client sensitive data. Organizations like CyberKnife Center of Miami are excellent examples to their peers on a proactive stance to cybersecurity. We are pleased to be assisting CyberKnife with their continued innovation and service to their clients.”

With December being Cancer Awareness month, Identillect is proud to support the CyberKnife Center and anticipates greater need as the growth in this sector of cancer treatment expands and we are excited to contribute to the growing security needs.

About CyberKnife Center of Miami

Established in December 2003, the CyberKnife Center of Miami is the first CyberKnife center to open in the Southeastern US and the 11th in the United States. Their world-class physicians are specially trained in stereotactic radiosurgery and are among the most experienced and qualified worldwide. CyberKnife Miami provides image-guided radiosurgery treatments using the CyberKnife. They treat tumors of the brain, spine, lung, kidney, pancreas, liver, prostate, head and neck, as well as other conditions throughout the body where radiation treatment is indicated.

About Identillect
Identillect Technologies is the leading provider of email encryption service Delivery Trust™, empowering enterprises of all sizes to protect their business and their client’s critical information against cyber security attacks. 

Delivery Trust™ is an award -winning, multi-platform plug-in, which gives users complete control of their emails, for one low price. One simple integration complies with all regulations and most importantly provides peace of mind. 

For more information, or your free trial, please visit

On Behalf of the Board of Directors of:


Todd Sexton
Chief Executive Officer
Tel: (949) 468-7878

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking.  Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements.  Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions.  There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties.  We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.